3rd Quarter - Report
ARNOLD & PORTER KAYE SCHOLER LLP for GENETIX BIOTHERAPEUTICS, INC.
Income
$60,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues and legislation related to access to gene therapies and treatment of rare diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBERT | — |
| RON KIND | — |
| BOBBY MCMILLIN | — |
| SONJA NESBIT | — |
| EUGENIA PIERSON | — |
Pharmacy PHA
Issues related to regulatory incentives for rare disease therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BOBBY MCMILLIN | — |
Medicare/Medicaid MMM
Issues and legislation related to access to gene therapies and treatment of rare diseases.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LUKE ALBERT | — |
| RON KIND | — |
| BOBBY MCMILLIN | — |
| SONJA NESBIT | — |
| EUGENIA PIERSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.